| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1996PNAS...9312490V |
| P356 | DOI | 10.1073/PNAS.93.22.12490 |
| P932 | PMC publication ID | 38019 |
| P698 | PubMed publication ID | 8901609 |
| P5875 | ResearchGate publication ID | 14304639 |
| P50 | author | C. Ronald Kahn | Q16106681 |
| P2093 | author name string | F Folli | |
| M F White | |||
| X J Sun | |||
| L A Velloso | |||
| M J Saad | |||
| P2860 | cites work | An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth | Q72284713 |
| Guanine nucleotide binding regulatory proteins in liver from obese humans with and without type II diabetes: evidence for altered "cross-talk" between the insulin receptor and Gi-proteins | Q72501624 | ||
| Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells | Q72591900 | ||
| Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle | Q72952422 | ||
| Insulin action impaired by deficiency of the G-protein subunit G ialpha2 | Q24320061 | ||
| Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1 | Q24322608 | ||
| Role of IRS-2 in insulin and cytokine signalling | Q24337494 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase | Q28115936 | ||
| PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase | Q28244045 | ||
| Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases | Q28288356 | ||
| Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor | Q28301248 | ||
| The insulin signaling system | Q28615921 | ||
| Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase | Q28618942 | ||
| The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 | ||
| Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism | Q34170571 | ||
| Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. | Q34714329 | ||
| Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans | Q35752273 | ||
| Increasing cAMP attenuates activation of mitogen-activated protein kinase | Q36645860 | ||
| Multisite phosphorylation of the alpha subunit of transducin by the insulin receptor kinase and protein kinase C. | Q37410606 | ||
| The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. | Q38287416 | ||
| Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor. | Q38289177 | ||
| Effects of diabetes mellitus on hepatocyte nuclear factor 1 decrease albumin gene transcription | Q38358742 | ||
| Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase | Q40018987 | ||
| PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. | Q40790718 | ||
| Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. | Q41851321 | ||
| Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance | Q42021393 | ||
| Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells | Q42490501 | ||
| Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor | Q42497288 | ||
| Insulin inhibits pertussis toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G-proteins | Q42513094 | ||
| Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation | Q42796185 | ||
| Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart | Q42821988 | ||
| Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase | Q42823635 | ||
| The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. | Q43408418 | ||
| ACE inhibitors--a cornerstone of the treatment of heart failure | Q44585380 | ||
| Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity | Q44786042 | ||
| Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme | Q49194198 | ||
| The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension. | Q54029916 | ||
| Diabetes. Causes of insulin resistance. | Q54180220 | ||
| A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor | Q58451438 | ||
| Involvement of MAP kinase activators in angiotensin II-induced activation of MAP kinases in cultured vascular smooth muscle cells | Q67503660 | ||
| Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart | Q68148786 | ||
| Insulin resistance in essential hypertension | Q68164220 | ||
| Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells | Q71143876 | ||
| Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells | Q72259808 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 12490-12495 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Cross-talk between the insulin and angiotensin signaling systems | |
| P478 | volume | 93 |
| Q35072984 | A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA" |
| Q47401971 | ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight |
| Q35131182 | AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells |
| Q35552931 | ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression |
| Q42986743 | ANG II inhibits insulin-mediated production of PI 3,4,5-trisphosphates via a Ca2+-dependent but PKC-independent pathway in the cardiomyocytes |
| Q45803207 | ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance |
| Q45115249 | Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression |
| Q40653974 | Activated Gαq Inhibits p110α Phosphatidylinositol 3-Kinase and Akt |
| Q40035883 | Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets |
| Q35924401 | Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation |
| Q56779715 | Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis |
| Q42913028 | Addition of Losartan to Angiotensin-Converting Enzyme Inhibitors Improves Insulin Resistance in Patients With Chronic Heart Failure Treated Without .BETA.-Blockers |
| Q31828807 | Adipose tissue as an endocrine organ? A review of some recent data |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q37374133 | Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk |
| Q28363300 | Angiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cells |
| Q80168023 | Angiotensin II modulates tyr-phosphorylation of IRS-4, an insulin receptor substrate, in rat liver membranes |
| Q34115852 | Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway |
| Q34496676 | Angiotensin II receptors and drug discovery in cardiovascular disease |
| Q30424204 | Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo |
| Q33299455 | Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth |
| Q30433343 | Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. |
| Q40442306 | Angiotensin II-induced hypertension in mice caused an increase in insulin secretion |
| Q53553738 | Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. |
| Q30393746 | Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor |
| Q42496798 | Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes |
| Q46922376 | Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis. |
| Q36507654 | Anti-diabetic effect of blockade of the renin-angiotensin system |
| Q33948469 | Antihypertensive drugs and glucose metabolism |
| Q46504544 | Association analysis of the variant in the regulatory subunit of phosphoinositide 3-kinase (p85alpha) with Type 2 diabetes mellitus and hypertension in the Chinese Han population |
| Q45997350 | B-type natriuretic peptide levels and insulin resistance in patients with severe ischemic myocardial dysfunction. |
| Q37380395 | Bidirectional modulation of insulin action by amino acids |
| Q28577340 | Blockade of IRS1 in isolated rat pancreatic islets improves glucose-induced insulin secretion |
| Q38970827 | Blocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice |
| Q37132930 | Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus |
| Q44848291 | C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity |
| Q35601234 | Central angiotensin II has catabolic action at white and brown adipose tissue |
| Q42454127 | Changes in dietary sodium consumption modulate GLUT4 gene expression and early steps of insulin signaling |
| Q52072606 | Characterization of insulin-resistance: role of receptor alteration in insulin-dependent diabetes mellitus, essential hypertension and cardiac hypertrophy. |
| Q62699269 | Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells |
| Q48249984 | Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension. |
| Q35138016 | Contribution of salt intake to insulin resistance associated with hypertension |
| Q36897316 | Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. |
| Q28478084 | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates |
| Q51371762 | Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes. |
| Q24554072 | Cross talk of pp125(FAK) and pp59(Lyn) non-receptor tyrosine kinases to insulin-mimetic signaling in adipocytes |
| Q39193265 | Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors |
| Q40893206 | Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells |
| Q53269812 | Cytokine-dependent activation of JAK-STAT pathway in Saccharomyces cerevisiae. |
| Q33699974 | Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients |
| Q33745917 | Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis |
| Q34276981 | Diabetes mellitus and diabetes-associated vascular disease |
| Q35238764 | Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients? |
| Q47675937 | Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis |
| Q45074259 | Direct Activation of the Angiotensin II Type-2 Receptors Enhances Muscle Microvascular Perfusion, Oxygenation and Insulin Delivery in Male Rats |
| Q37973874 | Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms |
| Q54104998 | Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. |
| Q37073212 | Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients |
| Q37257697 | Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients |
| Q34163164 | Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin |
| Q34506453 | Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus. |
| Q45154726 | Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats |
| Q34655075 | Endothelial dysfunction in insulin resistance and type 2 diabetes |
| Q42818508 | Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes |
| Q45142910 | Endurance exercise training increases insulin responsiveness in isolated adipocytes through IRS/PI3-kinase/Akt pathway |
| Q53689502 | Erythropoietin deficiency in hyporeninemia. |
| Q33539997 | From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance |
| Q40355032 | Galphaq binds to p110alpha/p85alpha phosphoinositide 3-kinase and displaces Ras. |
| Q39570926 | Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration. |
| Q36214650 | High-Throughput Analysis of Mammalian Receptor Tyrosine Kinase Activation in Yeast Cells |
| Q35104210 | High-throughput de novo screening of receptor agonists with an automated single-cell analysis and isolation system |
| Q28565051 | Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways |
| Q34990507 | Hypertension and insulin disorders |
| Q47612824 | Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? |
| Q30433501 | Hypertension management and microvascular insulin resistance in diabetes |
| Q36916389 | IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms. |
| Q28565588 | Identification of the rat adapter Grb14 as an inhibitor of insulin actions |
| Q38124176 | Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure |
| Q44472077 | Influence of plasma insulin levels on antinatriuretic and vasoconstrictor actions of angiotensin-II. |
| Q57475446 | Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis |
| Q48228017 | Insulin induces tyrosine phosphorylation of the insulin receptor and SHC, and SHC/GRB2 association in cerebellum but not in forebrain cortex of rats |
| Q41014152 | Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells. |
| Q33703478 | Insulin signalling: metabolic pathways and mechanisms for specificity |
| Q36899312 | Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes |
| Q35753591 | Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients |
| Q37421817 | JAK-STAT signaling and myocardial glucose metabolism |
| Q36037520 | Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance |
| Q28742760 | Long-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system components |
| Q35744489 | Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study |
| Q33883164 | Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin resistance |
| Q42460739 | Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice |
| Q35159242 | Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease |
| Q36674821 | Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? |
| Q37896522 | Metabolic syndrome: its history, mechanisms, and limitations |
| Q36910745 | Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension |
| Q37924914 | Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. |
| Q38072622 | Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance |
| Q38180800 | Modulation of the action of insulin by angiotensin-(1-7). |
| Q38312460 | Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists |
| Q44367139 | Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold |
| Q35661518 | Morphine induces desensitization of insulin receptor signaling |
| Q40891663 | Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting |
| Q91970526 | NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells |
| Q37626852 | Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications |
| Q33937005 | Nutrient modulation of cellular insulin action |
| Q73500427 | Obesity and hypertension |
| Q28578260 | PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1 |
| Q42451812 | Peroxisome proliferator-activated receptor gamma coactivator-1-dependent uncoupling protein-2 expression in pancreatic islets of rats: a novel pathway for neural control of insulin secretion. |
| Q37163737 | Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome |
| Q42991205 | Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling |
| Q40625747 | Phospholipase C-independent Activation of Glycogen Synthase Kinase-3β and C-terminal Src Kinase by Gαq |
| Q35074218 | Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. |
| Q30002306 | Predicting Kinase Activity in Angiotensin Receptor Phosphoproteomes Based on Sequence-Motifs and Interactions |
| Q37172937 | Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons |
| Q35933720 | Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system |
| Q40825828 | Regulation of angiotensin II type 1 (AT1) receptor function |
| Q30427254 | Regulation of muscle microcirculation in health and diabetes |
| Q37058920 | Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature |
| Q38833827 | Regulatory mechanisms in arterial hypertension: role of microRNA in pathophysiology and therapy |
| Q36349311 | Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen |
| Q36020654 | Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms |
| Q38375202 | Renin-angiotensin system: an old player with novel functions in skeletal muscle |
| Q44230853 | Reversal of denervation-induced insulin resistance by SHIP2 protein synthesis blockade |
| Q35087587 | Role of ACE inhibitors in treating hypertensive diabetic patients |
| Q47132051 | Roles of renin-angiotensin system and Wnt pathway in aging-related phenotypes |
| Q101574203 | SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells |
| Q50899263 | Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. |
| Q36092619 | Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle |
| Q34019805 | Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase |
| Q42989406 | Signalling pathways of an insulin-mimetic phosphoinositolglycan-peptide in muscle and adipose tissue |
| Q22010243 | Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors |
| Q42372400 | Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues |
| Q38553529 | Targeting inflammation in metabolic syndrome. |
| Q39238938 | The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension |
| Q33933167 | The biochemical and physiological characteristics of receptors |
| Q44670819 | The influence of ageing on the insulin signalling system in rat lacrimal and salivary glands |
| Q30311092 | The intrarenal renin-angiotensin system and diabetic nephropathy |
| Q39020203 | The intricacies of the renin-angiotensin-system in metabolic regulation. |
| Q37362674 | The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? |
| Q36359129 | The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. |
| Q36550987 | The renin angiotensin aldosterone system and insulin resistance in humans |
| Q33915412 | The renin angiotensin system and the metabolic syndrome |
| Q30442722 | The renin-angiotensin system and insulin resistance |
| Q37924374 | The renin-angiotensin-aldosterone system and glucose homeostasis |
| Q34984896 | The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance |
| Q36709546 | The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? |
| Q34698743 | The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications |
| Q35087387 | The use of ACE inhibitors on diabetic patients without renal disease |
| Q36576550 | Toll-like receptor 4, F4/80 and pro-inflammatory cytokines in intestinal and mesenteric fat tissue of Crohn's disease |
| Q45944027 | Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension. |
| Q42522124 | Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats |
| Q38006726 | Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options. |
| Q28580814 | Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats |
| Q34718367 | Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial |
| Q39242378 | Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. |
| Q45306500 | beta3-Adrenergic-dependent and -independent mechanisms participate in cold-induced modulation of insulin signal transduction in brown adipose tissue of rats |
Search more.